EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comprehensive analysis of adverse events associated with transmural use of LAMS in patients with liver cirrhosis: International multicenter study

Umfassende Analyse von unerwünschten Ereignissen bei transmurale Anwendung von LAMS bei Patient:innen mit Leberzirrhose: internationale multizentrische Studie

Faisal Nimri iD, Yervant Ichkhanian, Brianna Shinn, Thomas E Kowalski, David E Loren, Anand Kumar, Alexander Schlachterman, Alina Tantau, Martha Arevalo, Ashraf Taha, Omar Shamaa, Maria Chavarria Viales und 5 weitere

Endoscopy International Open · 01.06.2024 · 12 (06) · E740-E749

DOI: 10.1055/a-2312-1528 ↗

Auf einen Blick

Bei 43 Patient:innen mit Leberzirrhose traten nach EUS-gestützter transmurale LAMS-Anlage 9 unerwünschte Ereignisse auf. Die meisten waren mild und konservativ behandelbar.

Fragestellung

Wie sicher ist die EUS-gestützte transmurale Anlage von LAMS bei Patient:innen mit Leberzirrhose?

Methode

Retrospektive, multizentrische, internationale gematchte Fall-Kontroll-Studie.

Ergebnisse

43 cirrhotic patients; 9 AEs. Häufigste AEs: Migration (3), mukosale Erosion ohne Blutung (2), verzögerte Blutung (2), Sepsis (1), Anästhesiekomplikation (1). 6 mild, 2 schwer, 1 moderat.

Einschränkungen

Retrospektiv; nur 43 Patient:innen; keine Assoziation möglicher Prädiktoren in der konditionalen logistischen Regression.

Schlussfolgerung der Autor:innen

Die Autor:innen berichten, dass die meisten AEs mild waren und konservativ behandelt werden konnten; weitere Studien zur Sicherheit bei Zirrhose seien erforderlich.

Kernaussagen

  • 9 unerwünschte Ereignisse nach EUS-gestützter TM-LAMS-Anlage
  • Die meisten Ereignisse waren mild und konservativ behandelbar
  • Weitere Studien zur Sicherheit bei Leberzirrhose erforderlich

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.06.2024. Verfasst von Faisal Nimri und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Endoscopic ultrasound (EUS)-guided transmural (TM) deployment of lumen-apposing metal stents (LAMS) is considered relatively safe in non-cirrhotic patients and is cautiously offered to cirrhotic patients. Patients and methods This was a retrospective, multicenter, international matched case-control study to study the safety of EUS-guided TM deployment of LAMS in cirrhotic patients.

Results

Forty-three cirrhotic patients with model for end-stage liver disease score 12.5 ± 5, with 23 having ascites and 16 with varices underwent EUS-guided TM LAMS deployment, including 19 for pancreatic fluid collection (PFC) drainage, 13 gallbladder drainage, six for endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography (ERCP), three for EDGI, one for endoscopic ultrasound-directed transenteric ERCP, and one postsurgical collection drainage. Technical failure occurred in one LAMS for PFC drainage. Clinical failure was encountered in another PFC. Nine adverse events (AEs) occurred. The most common AE was LAMS migration (3), followed by non-bleeding mucosal erosion (2), delayed bleeding (2), sepsis (1), and anesthesia-related complication (pulseless electrical activity) (1). Most AEs were graded as mild (6), followed by severe (2), and moderate (1); the majority were managed conservatively. On univariable comparison, risk of AE was higher when using a 20 × 10 mm LAMS and the absence of through-the-LAMS plastic stent(s). Conditional logistic regression of matched case-control patients did not show any association between potential predicting factors and occurrence of AEs.

Conclusions

Our study demonstrated that mainly in patients with Child-Pugh scores A and B cirrhosis and despite the presence of mild-to-moderate ascites in over half of cases, the majority of AEs were mild and could be managed conservatively. Further studies are warranted to verify the safety of LAMS in cirrhotic patients.

Schlagwörter

Stichwörter der Autor:innen

Biliary tractDilation, injection, stentingEndoscopic ultrasonographyEndoscopy Upper GI TractIntervention EUSPerformance and complicationsPortal hypertension and variceal bleedingQuality and logistical aspects

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, United States.
  • Department of Internal Medicine, Henry Ford Hospital, Detroit, United States.
  • Division of Gastroenterology and Hepatology, Thomas Jefferson Hospital, Wayne, United States.
  • Division of Gastroenterology and Hepatology Medical Center, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Instituto Ecuatoriano de Enfermedades Digestivas (IECED), Guayaquil, Ecuador.
  • Gastroenterology, Universidad Internacional de las Americas, San Jose, Costa Rica.

ORCID-Profile: Faisal Nimri

Zitieren

APA

Nimri, F., Ichkhanian, Y., Shinn, B., Kowalski, T. E., Loren, D. E., Kumar, A., Schlachterman, A., Tantau, A., Arevalo, M., Taha, A., Shamaa, O., Viales, M. C., Khashab, M. A., Simmer, S., Singla, S., Piraka, C., & Zuchelli, T. E. (2024). Comprehensive analysis of adverse events associated with transmural use of LAMS in patients with liver cirrhosis: International multicenter study. Endoscopy International Open, 12(06), E740-E749. https://doi.org/10.1055/a-2312-1528

Vancouver

Nimri F, Ichkhanian Y, Shinn B, Kowalski TE, Loren DE, Kumar A, et al. Comprehensive analysis of adverse events associated with transmural use of LAMS in patients with liver cirrhosis: International multicenter study. Endoscopy International Open. 2024;12(06):E740-E749. doi:10.1055/a-2312-1528

BibTeX
@article{Nimri2024,
  author = {Nimri, Faisal and Ichkhanian, Yervant and Shinn, Brianna and Kowalski, Thomas E and Loren, David E and Kumar, Anand and Schlachterman, Alexander and Tantau, Alina and Arevalo, Martha and Taha, Ashraf and Shamaa, Omar and Viales, Maria Chavarria and Khashab, Mouen A and Simmer, Stephen and Singla, Sumit and Piraka, Cyrus and Zuchelli, Tobias E},
  title = {Comprehensive analysis of adverse events associated with transmural use of LAMS in patients with liver cirrhosis: International multicenter study},
  journal = {Endoscopy International Open},
  year = {2024},
  volume = {12},
  number = {06},
  pages = {E740--E749},
  doi = {10.1055/a-2312-1528}
}
Kostenlos starten →